Skip to main content

Advertisement

SpringerLink
Log in

How good is the levothyroxine replacement in primary hypothyroidism patients in Brazil? Data of a multicentre study

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background: Studies from every continent have shown that only around 50% of the patients subjected to thyroid hormone replacement have TSH in the normal range. However, to date, there are no consistent data about Brazil. Objectives: To evaluate levothyroxine (LT4) replacement treatment in patients with primary hypothyroidism followed in referral centers in Brazil. Methods: Patients with primary hypothyroidism followed in referral centers (University Hospitals from Universidade Federal do Rio de Janeiro — UFRJ, Unicamp, Universidade Federal do Paraná — UFPR and Universidade Federal do Ceará-UFC) answered a questionnaire that inquired about clinical and biochemical conditions, social-economic status, life quality and clinicians’ orientations as well as their understanding about the information given. Serum TSH was checked close to the interview. Results: 2292 consecutive patients met the inclusion criteria. Mean age 51.2 yr and TSH values between 0.4 and 4.0 mUI/l were considered to be within the reference range. Among all patients taking thyroid medication, 42.7% had an abnormal serum TSH (28.3% were undertreated and 14.4% were overtreated). Approximately all patients (99%) took LT4 in the morning but less than 30 min before breakfast (85.4%). Regarding the clinicians’ orientations: 97.5% of the patients were instructed to take the medication daily, and 92.6% to take 30 min before breakfast (92.6%). However, only 52.1% were told not to take LT4 along with other medication. Conclusions: Our study found that a significant number of patients taking thyroid hormones were not in the therapeutic range. Clinicians should, therefore, consider monitoring patients on thyroid replacement more frequently and being more precise on giving recommendations about the correct use of LT4.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977, 7: 481–93.

    Article  Google Scholar 

  2. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995, 43: 55–68.

    Article  Google Scholar 

  3. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000, 160: 526–34.

    Article  PubMed  Google Scholar 

  4. Sichieri R, Baima J, Marante T, de Vasconcellos MT, Moura AS, Vaisman M. Low prevalence of hypothyroidism among black and Mulatto people in a population-based study of Brazilian women. Clin Endocrinol (Oxf) 2007, 66: 803–7.

    Article  Google Scholar 

  5. Harington CR, Barger G. Chemistry of thyroxine - constitution and synthesis of thyroxine. Biochem J 1927, 21: 169–83.

    PubMed Central  PubMed  Google Scholar 

  6. Mitchell AL, Hickey B, Hickey JL, Pearce SHS. Trends in thyroid hormone prescribing and consumption in the UK. BMC Public Health 2009, 9: 132.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Nicholls JJ, Brassill MJ, Williams GR, Bassett JH. The skeletal consequences of thyrotoxicosis. J Endocrinol 2012, 213: 209–21.

    Article  PubMed  Google Scholar 

  8. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994, 331: 1249–52.

    Article  PubMed  Google Scholar 

  9. Collet TH, Gussekloo J, Bauer DC, et al, for the Thyroid Studies Collaboration. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 2012, 172: 799–809.

    Article  PubMed  Google Scholar 

  10. Teixeira P de F, Reuters VS, Ferreira MM, et al. Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. Transl Res 2008, 151: 224–31.

    Article  Google Scholar 

  11. Martins RM, Fonseca RH, Duarte MM, et al. Impact of subclinical hypothyroidism treatment in systolic and diastolic cardiac function. Arq Bras Endocrinol Metab 2011, 55: 460–7.

    Article  Google Scholar 

  12. McMillan C, Bradley C, Razvi S, Weaver J. Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: The ThyDQoL and ThySRQ. Value Health 2008, 11: 285–94.

    Article  PubMed  Google Scholar 

  13. Cooper DS. Subclinical hypothyroidism. N Engl J Med 2001, 345: 260–5.

    Article  PubMed  Google Scholar 

  14. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008, 29: 76–131.

    Article  PubMed  Google Scholar 

  15. Fatourechi V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc 2009, 84: 65–71.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004, 291: 228–38.

    Article  PubMed  Google Scholar 

  17. Zamfirescu I, Carlson HE. Absorption of levothyroxine when coadministered with various calcium formulations. Thyroid 2011, 21: 483–6.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Kong WM, Sheikh MH, Lumb PJ, et al. A 6-month randomized trialof thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med 2002, 112: 348–54.

    Article  PubMed  Google Scholar 

  19. Teixeira P de F, Reuters VS, Almeida CP, et al. Evaluation of clinical and psychiatric symptoms in subclinical hypothyroidism. Rev Assoc Med Bras 2006, 52: 222–8.

    Article  Google Scholar 

  20. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab 2007, 92: 1715–23.

    Article  PubMed  Google Scholar 

  21. Zhu DF, Wang ZX, Zhang DR, et al. fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism. Brain 2006, 129: 2923–30.

    Article  PubMed  Google Scholar 

  22. Parle J, Roberts L, Wilson S, et al. A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study. J Clin Endocrinol Metab 2010, 95: 3623–32.

    Article  PubMed  Google Scholar 

  23. Biondi B, Palmieri EA, Fazio S, et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 2000; 85: 4701–5.

    PubMed  Google Scholar 

  24. Sgarbi JA, Villaca F, Garbeline B, Villar HE, Romaldini JH. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism on clinical and heart abnormalities. J Clin Endocrinol Metab 2003, 88: 1672–7.

    Article  PubMed  Google Scholar 

  25. Auer JA, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 2001, 142: 838–42.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrinology Service, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil

    F. Vaisman MD & M. Vaisman

  2. Institute of Public Health Studies, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil

    C. Medina Coeli

  3. Endocrinology Service, Universidade de Campinas, Campinas, SP, Brazil

    L. S. Ward

  4. Endocrinology Service, Universidade Federal do Paraná, Curitiba, PR, Brazil

    H. Graf & G. Carvalho

  5. Endocrinology Service, Universidade Federal do Ceará, Fortaleza, CE, Brazil

    R. Montenegro Jr

Authors
  1. F. Vaisman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Medina Coeli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. S. Ward
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Graf
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Carvalho
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Montenegro Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Vaisman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Vaisman MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vaisman, F., Coeli, C.M., Ward, L.S. et al. How good is the levothyroxine replacement in primary hypothyroidism patients in Brazil? Data of a multicentre study. J Endocrinol Invest 36, 485–488 (2013). https://doi.org/10.3275/8810

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3275/8810

Key-words

Search

Navigation